170 related articles for article (PubMed ID: 9174210)
1. In vitro assessment of the effect of clavulanic acid at concentrations achieved in human serum on the bactericidal activity of amoxicillin at physiological concentrations against Staphylococcus aureus: implications for dosage regimens.
Aguilar L; Martín M; Balcabao IP; Gómez-Lus ML; Dal-Ré R; Prieto J
Antimicrob Agents Chemother; 1997 Jun; 41(6):1403-5. PubMed ID: 9174210
[TBL] [Abstract][Full Text] [Related]
2. Postantibiotic and post-beta-lactamase inhibitor effects of amoxicillin plus clavulanate.
Thorburn CE; Molesworth SJ; Sutherland R; Rittenhouse S
Antimicrob Agents Chemother; 1996 Dec; 40(12):2796-801. PubMed ID: 9124843
[TBL] [Abstract][Full Text] [Related]
3. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
Etesse-Carsenti H; Garraffo R; Bernard E; de Salvador F; Pradier C; Durant J; Mondain V; Drugeon HB; Dellamonica P
Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
[TBL] [Abstract][Full Text] [Related]
4. In vitro bactericidal activity of peak serum concentrations of co-amoxiclav, amoxicillin and vancomycin against methicillin-resistant Staphylococcus aureus.
Gómez-Lus ML; Prieto J; Giménez MJ; García M; Anta L; Aguilar L
Rev Esp Quimioter; 1999 Jun; 12(2):136-9. PubMed ID: 10562674
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of co-amoxiclav at concentrations achieved in human serum against the resistant subpopulation of heteroresistant Staphylococcus aureus: a controlled study with vancomycin.
Prieto J; Aguilar L; Giménez MJ; Toro D; Gómez-Lus ML; Dal-Ré R; Balcabao IP
Antimicrob Agents Chemother; 1998 Jul; 42(7):1574-7. PubMed ID: 9660985
[TBL] [Abstract][Full Text] [Related]
6. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
Cuffini AM; Tullio V; Allocco A; Paizis G; Carlone NA
Microbios; 1996; 87(350):31-8. PubMed ID: 8972100
[TBL] [Abstract][Full Text] [Related]
7. Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
Bedenić B; Zagar Z
J Chemother; 1994 Dec; 6(6):383-7. PubMed ID: 7699424
[TBL] [Abstract][Full Text] [Related]
8. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
Torrico M; Aguilar L; González N; Giménez MJ; Echeverría O; Cafini F; Sevillano D; Alou L; Coronel P; Prieto J
Antimicrob Agents Chemother; 2007 Oct; 51(10):3699-706. PubMed ID: 17664320
[TBL] [Abstract][Full Text] [Related]
9. Effect of low concentrations of clavulanic acid on the in-vitro activity of amoxycillin against beta-lactamase-producing Branhamella catarrhalis and Haemophilus influenzae.
Cooper CE; Slocombe B; White AR
J Antimicrob Chemother; 1990 Sep; 26(3):371-80. PubMed ID: 2121699
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
Cuffini AM; De Renzi G; Tullio V; Paizis G; Carlone NA
Drugs Exp Clin Res; 1996; 22(1):9-15. PubMed ID: 8839632
[TBL] [Abstract][Full Text] [Related]
11. [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].
Bémer-Melchior P; Gilly L; Jugroot-Klotz K; Brun T; Névot P; Paul G
Pathol Biol (Paris); 1995 Nov; 43(9):760-5. PubMed ID: 8746097
[TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics of amoxicillin/clavulanic acid against Haemophilus influenzae in an in vitro kinetic model: a comparison of different dosage regimens including a pharmacokinetically enhanced formulation.
Löwdin E; Cars O; Odenholt I
Clin Microbiol Infect; 2002 Oct; 8(10):646-53. PubMed ID: 12390283
[TBL] [Abstract][Full Text] [Related]
13. [Bactericidal activity of combinations of ticarcillin-clavulanic acid or other beta-lactams (amoxicillin, piperacillin-tazobactam, ticarcillin) with gentamicin against Enterococcus faecalis and E. faecium].
Leclercq R; Duval J
Pathol Biol (Paris); 1995 Apr; 43(4):245-52. PubMed ID: 7567109
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime.
Skov R; Frimodt-Møller N; Espersen F
APMIS; 2002 Aug; 110(7-8):559-64. PubMed ID: 12390414
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
Hsu LY; Chang SC; Luh KT; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
[TBL] [Abstract][Full Text] [Related]
16. Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid. Evaluation of oxacillin-resistant and oxacillin-susceptible isolates.
Barry AL
Diagn Microbiol Infect Dis; 1990; 13(5):357-61. PubMed ID: 2282775
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
Paniagua GL; Monroy E; García O; Vaca S
Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
[TBL] [Abstract][Full Text] [Related]
18. [A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
Acar N; Diri MC; Türkyilmaz FR
Mikrobiyol Bul; 1987 Oct; 21(4):284-8. PubMed ID: 3332705
[TBL] [Abstract][Full Text] [Related]
19. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
Stein GE; Gurwith MJ
Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
[TBL] [Abstract][Full Text] [Related]
20. Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Bingen E; Bourgeois F; Chardon H; Doit C; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):923-6. PubMed ID: 1486888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
